Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(1H-IMidazol-4-yl)-piperidine-1-carboxylic acid tert-butyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

152241-38-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 152241-38-8 Structure
  • Basic information

    1. Product Name: 4-(1H-IMidazol-4-yl)-piperidine-1-carboxylic acid tert-butyl ester
    2. Synonyms: 4-(1H-IMidazol-4-yl)-piperidine-1-carboxylic acid tert-butyl ester;tert-butyl 4-(1H-imidazol-5-yl)piperidine-1-carboxylate
    3. CAS NO:152241-38-8
    4. Molecular Formula: C13H21N3O2
    5. Molecular Weight: 251.32474
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 152241-38-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 430.0±38.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.140±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 14.39±0.10(Predicted)
    10. CAS DataBase Reference: 4-(1H-IMidazol-4-yl)-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-(1H-IMidazol-4-yl)-piperidine-1-carboxylic acid tert-butyl ester(152241-38-8)
    12. EPA Substance Registry System: 4-(1H-IMidazol-4-yl)-piperidine-1-carboxylic acid tert-butyl ester(152241-38-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 152241-38-8(Hazardous Substances Data)

152241-38-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 152241-38-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,2,4 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 152241-38:
(8*1)+(7*5)+(6*2)+(5*2)+(4*4)+(3*1)+(2*3)+(1*8)=98
98 % 10 = 8
So 152241-38-8 is a valid CAS Registry Number.

152241-38-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-propanyl 4-(1H-imidazol-4-yl)-1-piperidinecarboxylate

1.2 Other means of identification

Product number -
Other names 4-(t-Butoxy-carbonyl-4-piperidyl)-1H-imidazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:152241-38-8 SDS

152241-38-8Downstream Products

152241-38-8Relevant articles and documents

GAMMA-AMINOAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

-

Page/Page column 71, (2010/02/07)

The present invention is directed to compounds of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R11, R12, W, X, and n are defined herein, which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

4-[4'-PIPERODINYL OR 3'-PIRROLIDINYL] SUBSTITUTED IMIDAZOLES AS H3 RECEPTOR ANTAGONISTS AND THERAPEUTIC USES THEREOF

-

, (2008/06/13)

Diazolyl compounds having activity as histamine H3-receptor antagonists, pharmaceutical compositions and methods of using such compounds for treating cognitive disorder or attention or arousal deficit.

HISTAMINE H3-RECEPTOR ANTAGONISTS AND THERAPEUTIC USES THEREOF

-

, (2008/06/13)

The present invention is directed to compounds of the class of piperidyl-imidazole derivative histamine H 3-receptor antagonists. Such compounds have affinity for histamine H 3-receptor, and preferably penetrate the blood-brain barrier. The compounds can

Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists

-

, (2008/06/13)

The present invention relates to a novel process for the preparation of highly potent histamine receptor antagonists, in particular histamine H 3 receptor antagonists. Also disclosed is a novel process for the preparation of intermediates useful in the preparation of histamine receptor antagonists, in particular H 3 -receptor antagonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 152241-38-8